176 related articles for article (PubMed ID: 20169656)
1. The prognosis of patients having received optimal therapy for nonvariceal upper gastrointestinal bleeding might be worse in daily practice than in randomized clinical trials.
Fein F; Weber A; Koch S; Festou N; Dupont-Gossard AC; Cervoni JP; Monnet E; Bardou M; Carbonnel F
Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):361-7. PubMed ID: 20169656
[TBL] [Abstract][Full Text] [Related]
2. Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis.
Liang CM; Lee JH; Kuo YH; Wu KL; Chiu YC; Chou YP; Hu ML; Tai WC; Chiu KW; Hu TH; Chuah SK
BMC Gastroenterol; 2012 Mar; 12():28. PubMed ID: 22455511
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of high dose bolus versus continuous intravenous infusion pantoprazole as an adjunct therapy to therapeutic endoscopy in massive bleeding peptic ulcer.
Yamada S; Wongwanakul P
J Med Assoc Thai; 2012 Mar; 95(3):349-57. PubMed ID: 22550833
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata.
Lanas A; Carrera-Lasfuentes P; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Polo-Tomas M; Calvet X; Feu F; Perez-Aisa A
Scand J Gastroenterol; 2014 Oct; 49(10):1181-90. PubMed ID: 25144754
[TBL] [Abstract][Full Text] [Related]
5. Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers.
Chen CC; Lee JY; Fang YJ; Hsu SJ; Han ML; Tseng PH; Liou JM; Hu FC; Lin TL; Wu MS; Wang HP; Lin JT
Aliment Pharmacol Ther; 2012 Apr; 35(8):894-903. PubMed ID: 22369682
[TBL] [Abstract][Full Text] [Related]
6. Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding.
Liu N; Liu L; Zhang H; Gyawali PC; Zhang D; Yao L; Yang Y; Wu K; Ding J; Fan D
J Gastroenterol Hepatol; 2012 Sep; 27(9):1473-9. PubMed ID: 22646140
[TBL] [Abstract][Full Text] [Related]
7. Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding: comparison of event rates in routine clinical practice and a clinical trial.
Lanas A; Polo-Tomas M; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Calvet X; Feu F; Perez-Aisa A; Sung JJ
Scand J Gastroenterol; 2013 Mar; 48(3):285-94. PubMed ID: 23298283
[TBL] [Abstract][Full Text] [Related]
8. Current managements and outcomes of peptic and artificial ulcer bleeding in Japan.
Fujishiro M; Abe N; Endo M; Kawahara Y; Shimoda R; Nagata S; Homma K; Morita Y; Uedo N
Dig Endosc; 2010 Jul; 22 Suppl 1():S9-14. PubMed ID: 20590780
[TBL] [Abstract][Full Text] [Related]
9. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA
J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding.
Mesihovic R; Vanis N; Mehmedovic A; Gornjakovic S; Gribajcevic M
Med Arh; 2009; 63(6):323-7. PubMed ID: 20380111
[TBL] [Abstract][Full Text] [Related]
11. Treatment and prognosis in peptic ulcer bleeding.
Laursen SB
Dan Med J; 2014 Jan; 61(1):B4797. PubMed ID: 24547604
[TBL] [Abstract][Full Text] [Related]
12. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial.
Sung JJ; Barkun A; Kuipers EJ; Mössner J; Jensen DM; Stuart R; Lau JY; Ahlbom H; Kilhamn J; Lind T;
Ann Intern Med; 2009 Apr; 150(7):455-64. PubMed ID: 19221370
[TBL] [Abstract][Full Text] [Related]
13. Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial.
Zargar SA; Javid G; Khan BA; Yattoo GN; Shah AH; Gulzar GM; Sodhi JS; Mujeeb SA; Khan MA; Shah NA; Shafi HM
J Gastroenterol Hepatol; 2006 Apr; 21(4):716-21. PubMed ID: 16677158
[TBL] [Abstract][Full Text] [Related]
14. Independent risk factors of 30-day outcomes in 1264 patients with peptic ulcer bleeding in the USA: large ulcers do worse.
Camus M; Jensen DM; Kovacs TO; Jensen ME; Markovic D; Gornbein J
Aliment Pharmacol Ther; 2016 May; 43(10):1080-9. PubMed ID: 27000531
[TBL] [Abstract][Full Text] [Related]
15. Safety and tolerability of high-dose intravenous esomeprazole for prevention of peptic ulcer rebleeding.
Kuipers EJ; Sung JJ; Barkun A; Mössner J; Jensen D; Stuart R; Lau JY; Ahlbom H; Lind T; Kilhamn J
Adv Ther; 2011 Feb; 28(2):150-9. PubMed ID: 21181319
[TBL] [Abstract][Full Text] [Related]
16. Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high-risk stigmata: a multicentre comparative study.
Andrews CN; Levy A; Fishman M; Hahn M; Atkinson K; Kwan P; Enns R
Can J Gastroenterol; 2005 Nov; 19(11):667-71. PubMed ID: 16292361
[TBL] [Abstract][Full Text] [Related]
17. Comparison of High Dose and Standard Dose Proton Pump Inhibitor before Endoscopy in Patients with Non-Portal Hypertension Bleeding.
Rattanasupar A; Sengmanee S
J Med Assoc Thai; 2016 Sep; 99(9):988-95. PubMed ID: 29927201
[TBL] [Abstract][Full Text] [Related]
18. Optimal dose of intravenous pantoprazole in patients with peptic ulcer bleeding requiring endoscopic hemostasis in Korea.
Choi KD; Kim N; Jang IJ; Park YS; Cho JY; Kim JR; Shin JM; Jung HC; Song IS
J Gastroenterol Hepatol; 2009 Oct; 24(10):1617-24. PubMed ID: 19686407
[TBL] [Abstract][Full Text] [Related]
19. High-dose vs. Low-dose Proton Pump Inhibitors post-endoscopic hemostasis in patients with bleeding peptic ulcer. A meta-analysis and meta-regression analysis.
Sgourakis G; Chatzidakis G; Poulou A; Malliou P; Argyropoulos T; Ravanis G; Vagia A; Kpogho I; Briki A; Tsuruhara H; Stankovičová T
Turk J Gastroenterol; 2018 Jan; 29(1):22-31. PubMed ID: 29391304
[TBL] [Abstract][Full Text] [Related]
20. High-dose omeprazole infusion compared with scheduled second-look endoscopy for prevention of peptic ulcer rebleeding: a randomized controlled trial.
Chiu PW; Joeng HK; Choi CL; Tsoi KK; Kwong KH; Lam SH; Sung JJ
Endoscopy; 2016 Aug; 48(8):717-22. PubMed ID: 27275859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
